These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21185195)

  • 1. Virtual screening and synthesis of quinazolines as novel JAK2 inhibitors.
    Yang SH; Khadka DB; Cho SH; Ju HK; Lee KY; Han HJ; Lee KT; Cho WJ
    Bioorg Med Chem; 2011 Jan; 19(2):968-77. PubMed ID: 21185195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based virtual screening of Src kinase inhibitors.
    Lee K; Kim J; Jeong KW; Lee KW; Lee Y; Song JY; Kim MS; Lee GS; Kim Y
    Bioorg Med Chem; 2009 Apr; 17(8):3152-61. PubMed ID: 19321350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naphtho[1,2-b]furan-4,5-dione disrupts Janus kinase-2 and induces apoptosis in breast cancer MDA-MB-231 cells.
    Lin KL; Su JC; Chien CM; Tseng CH; Chen YL; Chang LS; Lin SR
    Toxicol In Vitro; 2010 Jun; 24(4):1158-67. PubMed ID: 20197088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 8-benzyl-4-oxo-8-azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylic acid (SD-1008), a novel janus kinase 2 inhibitor, increases chemotherapy sensitivity in human ovarian cancer cells.
    Duan Z; Bradner J; Greenberg E; Mazitschek R; Foster R; Mahoney J; Seiden MV
    Mol Pharmacol; 2007 Nov; 72(5):1137-45. PubMed ID: 17675586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WP1066 disrupts Janus kinase-2 and induces caspase-dependent apoptosis in acute myelogenous leukemia cells.
    Ferrajoli A; Faderl S; Van Q; Koch P; Harris D; Liu Z; Hazan-Halevy I; Wang Y; Kantarjian HM; Priebe W; Estrov Z
    Cancer Res; 2007 Dec; 67(23):11291-9. PubMed ID: 18056455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel 2,4-disubstituted quinazolines as cytotoxic agents and JAK2 inhibitors: Synthesis, in vitro evaluation and molecular dynamics studies.
    Jyothi Buggana S; Paturi MC; Perka H; Gade DR; Vvs RP
    Comput Biol Chem; 2019 Apr; 79():110-118. PubMed ID: 30785020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells.
    Behera R; Kumar V; Lohite K; Karnik S; Kundu GC
    Carcinogenesis; 2010 Feb; 31(2):192-200. PubMed ID: 19926637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel small molecule deubiquitinase inhibitor blocks Jak2 signaling through Jak2 ubiquitination.
    Kapuria V; Levitzki A; Bornmann WG; Maxwell D; Priebe W; Sorenson RJ; Showalter HD; Talpaz M; Donato NJ
    Cell Signal; 2011 Dec; 23(12):2076-85. PubMed ID: 21855629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taking quinazoline as a general support-Nog to design potent and selective kinase inhibitors: application to FMS-like tyrosine kinase 3.
    Li WW; Chen JJ; Zheng RL; Zhang WQ; Cao ZX; Yang LL; Qing XY; Zhou LX; Yang L; Yu LD; Chen LJ; Wei YQ; Yang SY
    ChemMedChem; 2010 Apr; 5(4):513-6. PubMed ID: 20140937
    [No Abstract]   [Full Text] [Related]  

  • 10. Hydrogen peroxide stimulates tetrahydrobiopterin synthesis through activation of the Jak2 tyrosine kinase pathway in vascular endothelial cells.
    Shimizu S; Hiroi T; Ishii M; Hagiwara T; Wajima T; Miyazaki A; Kiuchi Y
    Int J Biochem Cell Biol; 2008; 40(4):755-65. PubMed ID: 18054268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor-induced ovarian carcinoma cell migration is associated with JAK2/STAT3 signals and changes in the abundance and localization of alpha6beta1 integrin.
    Colomiere M; Findlay J; Ackland L; Ahmed N
    Int J Biochem Cell Biol; 2009 May; 41(5):1034-45. PubMed ID: 18930836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of 1-methyl-1H-imidazole derivatives as potent Jak2 inhibitors.
    Su Q; Ioannidis S; Chuaqui C; Almeida L; Alimzhanov M; Bebernitz G; Bell K; Block M; Howard T; Huang S; Huszar D; Read JA; Rivard Costa C; Shi J; Su M; Ye M; Zinda M
    J Med Chem; 2014 Jan; 57(1):144-58. PubMed ID: 24359159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disubstituted 4(3H) quinazolones: a novel class of antitumor agents.
    Srivastava V; Srivastava AM; Tiwari AK; Srivastava R; Sharma R; Sharma H; Singh VK
    Chem Biol Drug Des; 2009 Sep; 74(3):297-301. PubMed ID: 19703032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The discovery of tricyclic pyridone JAK2 inhibitors. Part 1: hit to lead.
    Siu T; Kozina ES; Jung J; Rosenstein C; Mathur A; Altman MD; Chan G; Xu L; Bachman E; Mo JR; Bouthillette M; Rush T; Dinsmore CJ; Marshall CG; Young JR
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7421-5. PubMed ID: 21044843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel chemotype of kinase inhibitors: Discovery of 3,4-ring fused 7-azaindoles and deazapurines as potent JAK2 inhibitors.
    Wang T; Ledeboer MW; Duffy JP; Salituro FG; Pierce AC; Zuccola HJ; Block E; Shlyakter D; Hogan JK; Bennani YL
    Bioorg Med Chem Lett; 2010 Jan; 20(1):153-6. PubMed ID: 19945871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and quantum chemical studies of new 4-aminoquinazoline derivatives as Aurora A/B kinase inhibitors.
    Zheng M; Zheng Y; Xue Y; Liu Y; An L; Zhang L; Ji M; Xue B; Wu X; Gong X; Gu N; Zhan X
    Chem Biol Drug Des; 2013 Mar; 81(3):399-407. PubMed ID: 23279802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of potent pyrazolo[4,3-h]quinazoline-3-carboxamides as multi-cyclin-dependent kinase inhibitors.
    Traquandi G; Ciomei M; Ballinari D; Casale E; Colombo N; Croci V; Fiorentini F; Isacchi A; Longo A; Mercurio C; Panzeri A; Pastori W; Pevarello P; Volpi D; Roussel P; Vulpetti A; Brasca MG
    J Med Chem; 2010 Mar; 53(5):2171-87. PubMed ID: 20141146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel quinazoline derivatives exhibit antitumor activity by inhibiting JAK2/STAT3.
    Qiao H; Zhao D; Shi H; Ren K; Li J; Li E
    Oncol Rep; 2015 Oct; 34(4):1875-82. PubMed ID: 26238612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological evaluation of novel quinazoline derivatives as potential antitumor agents: molecular docking study.
    El-Azab AS; Al-Omar MA; Abdel-Aziz AA; Abdel-Aziz NI; el-Sayed MA; Aleisa AM; Sayed-Ahmed MM; Abdel-Hamide SG
    Eur J Med Chem; 2010 Sep; 45(9):4188-98. PubMed ID: 20599299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrrole-3-carboxamides as potent and selective JAK2 inhibitors.
    Brasca MG; Nesi M; Avanzi N; Ballinari D; Bandiera T; Bertrand J; Bindi S; Canevari G; Carenzi D; Casero D; Ceriani L; Ciomei M; Cirla A; Colombo M; Cribioli S; Cristiani C; Della Vedova F; Fachin G; Fasolini M; Felder ER; Galvani A; Isacchi A; Mirizzi D; Motto I; Panzeri A; Pesenti E; Vianello P; Gnocchi P; Donati D
    Bioorg Med Chem; 2014 Sep; 22(17):4998-5012. PubMed ID: 25009002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.